TheEdgeResearch
Home / Stocks / HYFT

MindWalk Holdings Corp. (HYFT)

NASDAQ Healthcare Biotechnology
$1.44 ▼ -1.37%
Market Cap
$67.3M
Sector
Healthcare
Industry
Biotechnology
Beta
0.83
52-Wk Range
0.99-3.246
CEO
Jennifer Lynne Bath
Country
US
Currency
USD

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded…

Open full interactive analysis & DCF →